Skip to content

UniSA BackOff! Study: Adelaide PrenaBelt Trial

UniSA BackOff! Study: A Randomized, Controlled, Five-way, Cross-over Trial to Evaluate the Effect of a Positional Therapy Device on Maternal Sleeping Position in the Third Trimester of Pregnancy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04437407
Enrollment
6
Registered
2020-06-18
Start date
2020-02-01
Completion date
2021-06-15
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Growth Retardation, Fetal Hypoxia, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Pregnancy Complications, Sleep-Disordered Breathing, Stillbirth

Keywords

Pregnancy, Sleep, Maternal

Brief summary

Stillbirth (SB) is a devastating complication of pregnancy and contributes to over 2 million deaths globally every year. Over 20 million infants are born every year with low birth weight (LBW), which is associated with a twenty times increased risk of death in the first year of life and high rates of short- and long-term illnesses. Sleeping on one's back during pregnancy has recently emerged as a potential risk factor for LBW and SB in the medical literature. In high-income countries, SB rates have mostly remained the same in the past two decades and targeting modifiable risk factors could help reduce the number of SB and LBW in the population. When a pregnant woman sleeps on her back, her body position compresses underlying blood vessels and reduces blood flow to the developing baby. This body position could cause unpleasant symptoms for the mother and result in LBW or SB of her baby. Lying on her side or with a slight lateral tilt helps relieve this compression. One way to keep people off their back while sleeping is by using positional therapy (PT). It is a simple, safe, inexpensive and effective intervention for preventing people who snore or people who's breathing pauses during sleep from sleeping on their back. Reducing the amount of time pregnant women sleep on their back could help reduce SB and LBW rates. The investigators developed a PT device (PrenaBelt) and tested it in three clinical trials, which demonstrated that it significantly decreases the number of time women spend sleeping on their back. Using feedback from our previous research, the investigators developed five additional devices that will be tested in this study. The purpose of this study is to evaluate the new PrenaBelt (PB2) prototypes' ability to reduce the amount of time pregnant women sleep on their backs in the third trimester of pregnancy, validate the Ajuvia Sleep Monitor, and collect feedback on the devices. Demonstrating that the sleeping position of pregnant women can be modified through the use of a simple, inexpensive PT intervention may be one of the keys to achieving significant reductions in LBW and late SB rates in Australia and worldwide.

Detailed description

The ability of the PB2 prototypes to reduce the amount of time pregnant women spend sleeping on their backs at night in the home setting in the third trimester of pregnancy will be evaluated via a consecutive, six-night, in-home, controlled, cross-over sleep study in third trimester pregnant women where the Ajuvia Sleep Monitor is validated against infrared video on the first night. Six nights: the first night is a control night with infrared video recording where only the Ajuvia is worn in passive mode to collect data on the participant's body position and is followed by five nights with the five different prototypes. Randomization: The order in which the different devices will be worn on the second night through fourth night, inclusive, will be determined by simple randomization. This will minimize the potential impact of changes to sleep across the nights resulting from familiarization with the equipment as the sleep tests proceed through the five non-control nights, which could bias the results. For logistical reasons, the sixth night is non-randomized and will include the Ajuvia in 'active' mode Cross-over: After the first night, on each of the subsequent four nights, the participants will cross over to a different PB2 device (depending on their randomization order) and cross over to the Ajuvia in 'active' mode on the sixth night to allow each participant to act as her own control for comparison of treatment effect on outcomes. In home: conducting this study in the home setting will allow for a more accurate representation of sleep patterns as the participants will be in the comfort of their own bed. Sleep test: The maternal pelvis position will be recorded while the participants are sleeping using the Ajuvia device. Going to bed- and wake-times, as well as experience with each device will be recorded daily in a sleep diary.

Interventions

DEVICEPB2-1 prototype

PB2-1 prototype is a belt-like wearable device similar to the original PrenaBelt designed for pregnant women that permits supine positioning of the pelvis but, when in this position, provides subtle pressure points to the user's body and thereby activates the body's natural mechanism to reposition itself to relieve discomfort. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

DEVICEPB2-2 prototype

PB2-2 prototype is a belt-like wearable device designed for pregnant women. When placed on the woman's back, this device prevents the pelvis from achieving a supine orientation by maintaining at least fifteen degrees of right or left lateral pelvic tilt. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

DEVICEPB2-3 prototype

PB2-3 prototype is a belt-like wearable device designed for pregnant women. When placed on the woman's back, this device prevents the pelvis from achieving a supine orientation by maintaining at least fifteen degrees of right or left lateral pelvic tilt. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

DEVICEPB2-4 prototype

PB2-4 prototype is a belt-like wearable device designed for pregnant women that prevents the user from achieving a supine position as the device allows right and left lateral pelvic tilt but prevents the user's pelvis from settling supine due to virtue of its design. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

DEVICEPB2-5 prototype

PB2-5 prototype is a belt-like wearable device designed for pregnant women that does not provide positional therapy. It can be worn anytime as a maternity support belt.

DEVICEAjuvia-Active

Ajuvia Sleep Monitor senses the user's body position and can be used in passive or active mode with or without the PB2 prototypes. In the active mode, it alerts the woman when her pelvis is in the supine position through a gentle vibratory alarm.

DEVICEAjuvia-Passive

Ajuvia Sleep Monitor senses the user's body position and can be used in passive or active mode with or without the PB2 prototypes. In the passive mode, it measures and records the position of the pelvis but does not alert the woman.

Sponsors

University of South Australia
CollaboratorOTHER
Shiphrah Biomedical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

A consecutive, six-night, in-home, controlled, cross-over sleep study in third-trimester pregnant women to validate the ability of the PB2 and Ajuvia devices to reduce the amount of time pregnant women spend sleeping on their backs at night in the home setting in the third trimester of pregnancy

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ≥18 years old * low-risk singleton pregnancy * in the last trimester of pregnancy (at least 28 weeks + 0 days but not more than 36 weeks + 0 days of gestation) * access to and ability to use iPhone (for downloading and using Ajuvia app) * residing in the Greater Adelaide Area.

Exclusion criteria

* musculoskeletal disorder that prevents sleeping supine or on a certain side (e.g., arthritic shoulder) * non-English speaking and reading

Design outcomes

Primary

MeasureTime frameDescription
Specificity of Ajuvia for left tilt position1 night (approximately 8 hours)The specificity(%) of the Ajuvia in determining the left pelvic tilt position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Sensitivity of Ajuvia for left lateral position1 night (approximately 8 hours)The sensitivity(%) of the Ajuvia in determining the left lateral pelvic position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Sensitivity of Ajuvia for supine position1 night (approximately 8 hours)The sensitivity(%) of the Ajuvia in determining the pelvic supine position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Specificity of Ajuvia for supine position1 night (approximately 8 hours)The specificity(%) of the Ajuvia in determining the pelvic supine position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Sensitivity of Ajuvia for prone position1 night (approximately 8 hours)The sensitivity(%) of the Ajuvia in determining the pelvic prone position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Specificity of Ajuvia for prone position1 night (approximately 8 hours)The specificity(%) of the Ajuvia in determining the pelvic prone position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Sensitivity of Ajuvia for left tilt position1 night (approximately 8 hours)The sensitivity(%) of the Ajuvia in determining the left pelvic tilt position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Specificity of Ajuvia for left lateral position1 night (approximately 8 hours)The specificity(%) of the Ajuvia in determining the left lateral pelvic position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Sensitivity of Ajuvia for right tilt position1 night (approximately 8 hours)The sensitivity(%) of the Ajuvia in determining the right pelvic tilt position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Specificity of Ajuvia for right tilt position1 night (approximately 8 hours)The specificity(%) of the Ajuvia in determining the right pelvic tilt position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Sensitivity of Ajuvia for right lateral position1 night (approximately 8 hours)The sensitivity(%) of the Ajuvia in determining the right lateral pelvic position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Specificity of Ajuvia for right lateral position1 night (approximately 8 hours)The specificity(%) of the Ajuvia in determining the right lateral pelvic position during night sleep against the gold-standard of position as determined by review of infrared video will be calculated using a two-by-two contingency table.
Supine Sleep Time - Control1 night (approximately 8 hours)The time (in minutes) spent sleeping in the supine position with Ajuvia in passive mode
Supine Sleep Time - PB2-11 night (approximately 8 hours)The time (in minutes) spent sleeping in the supine position with PB2-1 and Ajuvia in passive mode
Supine Sleep Time - PB2-21 night (approximately 8 hours)The time (in minutes) spent sleeping in the supine position with PB2-2 and Ajuvia in passive mode
Supine Sleep Time - PB2-31 night (approximately 8 hours)The time (in minutes) spent sleeping in the supine position with PB2-3 and Ajuvia in passive mode
Supine Sleep Time - PB2-41 night (approximately 8 hours)The time (in minutes) spent sleeping in the supine position with PB2-4 and Ajuvia in passive mode
Supine Sleep Time - PB2-51 night (approximately 8 hours)The time (in minutes) spent sleeping in the supine position with PB2-5 and Ajuvia in active mode
Prone Sleep Time - Control1 night (approximately 8 hours)The time (in minutes) spent sleeping in the prone position with Ajuvia in passive mode
Prone Sleep Time - PB2-11 night (approximately 8 hours)The time (in minutes) spent sleeping in the prone position with PB2-1 and Ajuvia in passive mode
Prone Sleep Time - PB2-21 night (approximately 8 hours)The time (in minutes) spent sleeping in the prone position with PB2-2 and Ajuvia in passive mode
Prone Sleep Time - PB2-31 night (approximately 8 hours)The time (in minutes) spent sleeping in the prone position with PB2-3 and Ajuvia in passive mode
Prone Sleep Time - PB2-41 night (approximately 8 hours)The time (in minutes) spent sleeping in the prone position with PB2-4 and Ajuvia in passive mode
Prone Sleep Time - PB2-51 night (approximately 8 hours)The time (in minutes) spent sleeping in the prone position with PB2-5 and Ajuvia in active mode
Left-tilt Sleep Time - Control1 night (approximately 8 hours)The time (in minutes) spent sleeping in the left pelvic tilt position with Ajuvia in passive mode
Left-tilt Sleep Time - PB2-11 night (approximately 8 hours)The time (in minutes) spent sleeping in the left pelvic tilt position with PB2-1 and Ajuvia in passive mode
Left-tilt Sleep Time - PB2-21 night (approximately 8 hours)The time (in minutes) spent sleeping in the left pelvic tilt position with PB2-2 and Ajuvia in passive mode
Left-tilt Sleep Time - PB2-31 night (approximately 8 hours)The time (in minutes) spent sleeping in the left pelvic tilt position with PB2-3 and Ajuvia in passive mode
Left-tilt Sleep Time - PB2-41 night (approximately 8 hours)The time (in minutes) spent sleeping in the left pelvic tilt position with PB2-4 and Ajuvia in passive mode
Left-tilt Sleep Time - PB2-51 night (approximately 8 hours)The time (in minutes) spent sleeping in the left pelvic tilt position with PB2-5 and Ajuvia in active mode
Left-lateral Sleep Time - Control1 night (approximately 8 hours)The time (in minutes) spent sleeping in the left lateral position with Ajuvia in passive mode
Left-lateral Sleep Time - PB2-11 night (approximately 8 hours)The time (in minutes) spent sleeping in the left lateral position with PB2-1 and Ajuvia in passive mode
Left-lateral Sleep Time - PB2-21 night (approximately 8 hours)The time (in minutes) spent sleeping in the left lateral position with PB2-2 and Ajuvia in passive mode
Left-lateral Sleep Time - PB2-31 night (approximately 8 hours)The time (in minutes) spent sleeping in the left lateral position with PB2-3 and Ajuvia in passive mode
Left-lateral Sleep Time - PB2-41 night (approximately 8 hours)The time (in minutes) spent sleeping in the left lateral position with PB2-4 and Ajuvia in passive mode
Left-lateral Sleep Time - PB2-51 night (approximately 8 hours)The time (in minutes) spent sleeping in the left-lateral position with PB2-5 and Ajuvia in active mode
Right-tilt Sleep Time - Control1 night (approximately 8 hours)The time (in minutes) spent sleeping in the right pelvic tilt position with Ajuvia in passive mode
Right-tilt Sleep Time - PB2-11 night (approximately 8 hours)The time (in minutes) spent sleeping in the right pelvic tilt position with PB2-1 and Ajuvia in passive mode
Right-tilt Sleep Time - PB2-21 night (approximately 8 hours)The time (in minutes) spent sleeping in the right pelvic tilt position with PB2-2 and Ajuvia in passive mode
Right-tilt Sleep Time - PB2-31 night (approximately 8 hours)The time (in minutes) spent sleeping in the right pelvic tilt position with PB2-3 and Ajuvia in passive mode
Right-tilt Sleep Time - PB2-41 night (approximately 8 hours)The time (in minutes) spent sleeping in the right pelvic tilt position with PB2-4 and Ajuvia in passive mode
Right-tilt Sleep Time - PB2-51 night (approximately 8 hours)The time (in minutes) spent sleeping in the right pelvic tilt position with PB2-5 and Ajuvia in active mode
Right-lateral Sleep Time - Control1 night (approximately 8 hours)The time (in minutes) spent sleeping in the right lateral position with Ajuvia in passive mode
Right-lateral Sleep Time - PB2-11 night (approximately 8 hours)The time (in minutes) spent sleeping in the right lateral position with PB2-1 and Ajuvia in passive mode
Right-lateral Sleep Time - PB2-21 night (approximately 8 hours)The time (in minutes) spent sleeping in the right lateral position with PB2-2 and Ajuvia in passive mode
Right-lateral Sleep Time - PB2-31 night (approximately 8 hours)The time (in minutes) spent sleeping in the right lateral position with PB2-3 and Ajuvia in passive mode
Right-lateral Sleep Time - PB2-41 night (approximately 8 hours)The time (in minutes) spent sleeping in the right lateral position with PB2-4 and Ajuvia in passive mode
Right-lateral Sleep Time - PB2-51 night (approximately 8 hours)The time (in minutes) spent sleeping in the right lateral position with PB2-5 and Ajuvia in active mode

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026